Details for New Drug Application (NDA): 019890
✉ Email this page to a colleague
The generic ingredient in STADOL is butorphanol tartrate. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the butorphanol tartrate profile page.
Summary for 019890
Tradename: | STADOL |
Applicant: | Bristol Myers Squibb |
Ingredient: | butorphanol tartrate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019890
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SPRAY, METERED;NASAL | Strength | 1MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 12, 1991 | TE: | RLD: | No |
Expired US Patents for NDA 019890
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bristol Myers Squibb | STADOL | butorphanol tartrate | SPRAY, METERED;NASAL | 019890-001 | Dec 12, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription